Tamoxifen Resistance and Epigenetic Modifications in Breast Cancer Cell Lines

E-ISSN： 1875-533x|14|28|3035-3043

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.28, 2007-12, pp. : 3035-3043

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion

Current Medicinal Chemistry, Vol. 22, Iss. 19, 2015-06 ,pp. : 2360-2374

Bentham Science Publishers

Access to resources Recommend Favorite

Tamoxifen Resistance in Breast Cancer: Elucidating Mechanisms

By Dorssers L.C.J.

Drugs, Vol. 61, Iss. 12, 2001-01 ,pp. : 1721-1733

Adis International

Access to resources Recommend Favorite

Mechanisms of Adipocytokine-Mediated Trastuzumab Resistance in HER2-Positive Breast Cancer Cell Lines

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 1, 2013-03 ,pp. : 31-41

Bentham Science Publishers

Access to resources Recommend Favorite

Tamoxifen link to breast cancer confirmed

Reactions Weekly, Vol. 1, Iss. 1269, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells

By Brooks Tracy O’Loughlin Kieran Minderman Hans Bundy Brian Ford Laurie Vredenburg Michael Bernacki Ralph Priebe Waldemar Baer Maria

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 115-122

Springer Publishing Company

Access to resources Recommend Favorite